ID CORE XT as a tool for molecular red blood cell typing

Area of Science:

• Transfusion Medicine
• Genetics
• Immunology

Background:

• Traditional serologic testing for human red blood cell (RBC) antigens has limitations.
• Molecular techniques have been developed to overcome these restrictions and identify key allelic variants.
• Personalized medicine, particularly for chronic transfusion patients, benefits from advanced RBC antigen detection.

Purpose of the Study:

• To review the ID CORE XT, a commercial DNA-based technique for RBC antigen genotyping.
• To highlight its utility in personalized medicine and transfusion management.

Main Methods:

• Review of the ID CORE XT platform, a Luminex-based technology.
• Discussion of its automated workflow post-DNA extraction.
• Reference to validation studies demonstrating robustness.

Main Results:

• The ID CORE XT facilitates mass-scale donor genotyping for RBC antigens.
• It aids in increasing the inventory of antigen-negative RBC units.
• The technology helps prevent immunization in chronically transfused patients through DNA-based compatibility matching.

Conclusions:

• The ID CORE XT is a valuable, automated tool for RBC antigen genotyping.
• It supports personalized transfusion strategies by enabling precise donor-recipient matching.
• This DNA-based approach enhances transfusion safety and efficacy.